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Introduction
Pediatric differentiated thyroid carcinoma (DTC), which comprises papillary (PTC) and follicular thyroid carcinoma (FTC), has an excellent prognosis with 15-year survival rates exceeding 95% (1) . The initial treatment in children generally consists of a (near) total thyroidectomy, followed by ablation therapy with radioiodine (131-I), although nowadays the latter often depends on risk stratification (2) (3) . TSH suppressive therapy with thyroid hormone has for decades been administered during follow-up to diminish the risk of recurrent disease. However, its use is currently reduced in patients without evidence of disease (4) (5) (6) . Long-term TSH suppressive therapy leads to subclinical hyperthyroidism.
Possible harmful late effects of long-term subclinical hyperthyroidism on cardiac function are increasingly being recognized (7-8). Subtle LV systolic dysfunction has been shown in adult patients with DTC on TSH suppressive therapy (9-10). Furthermore, diastolic dysfunction has been reported in adult patients with DTC after long-term TSH suppression (9). In addition to echocardiographic changes, plasma cardiac biomarkers may indicate (subclinical) cardiac dysfunction and may contribute to understanding the mechanisms underlying cardiac damage. An increased risk of atrial fibrillation (AF) has been described in adult patients with DTC. A higher cumulative radioiodine dose was associated with increased AF risk, while TSH levels were not (11).
Late cardiac effects of treatment in survivors of pediatric DTC have yet to be assessed. Detailed insight into possible late adverse events is needed to improve treatment guidelines and follow-up strategies in the still growing population of survivors of pediatric DTC. We therefore studied: 1) the prevalence of cardiac dysfunction in long-term survivors of pediatric DTC in relation to treatment variables including TSH level during follow-up, 2) the association between cardiac dysfunction and plasma biomarkers (N-Terminal pro-brain natriuretic peptide (NT-proBNP), high-sensitive Troponin-T (hs-Troponin-T), galectin-3), and 3) the prevalence of AF in this patient group. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Downloaded by University of Groningen Netherlands from online.liebertpub.com at 11/19/17. For personal use only.
Thyroid Diastolic dysfunction is common in survivors of pediatric differentiated thyroid carcinoma (DOI: 10.1089/thy.2017.0383) This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Patients and methods

Study design and population
This study is part of a nationwide Dutch study on pediatric DTC, previously described in detail (12) . For this study on cardiac endpoints, subjects who met the following inclusion criteria were invited to participate: (a) PTC or FTC diagnosed between January 1970 and months before evaluation. Reference data for echocardiography were derived from the recommendations of the American Society of Echocardiography (13) (14) (15) .
Echocardiographic measurements were also compared to those of an external control group, derived from another Dutch cohort study that included unaffected siblings of childhood-cancer survivors. Details on the methodology of this control group are described elsewhere (16) . Each survivor was matched with a control subject based on sex and, as best as possible, age at time of cardiac assessment. Details on the methodology of the control group are described elsewhere (16) . The Institutional Review Board of the University Medical Center Groningen approved the study. Written informed consent was obtained from all subjects. Assessments of survivors were performed between November 2012 and September 2014 and included medical history, a health and risk factor questionnaire, a physical examination, echocardiography and blood sampling. Assessments of controls were performed between August 2004 and April 2007.
Clinical and cardiac examinations
A single physician (MSKH) performed the physical examinations. Echocardiographic image acquisition was performed locally according to a pre-specified image acquisition protocol.
Images were stored digitally in DICOM format for offline central analysis at the Groningen Imaging Core Laboratory on an EchoPac analysis system, software version BT12 (General Electric, Horton, Norway). Echocardiographic evaluation consisted of left ventricular (LV) dimensions and volumes. Where appropriate, results were indexed for body surface area.
Assessment of LV systolic function consisted of LV ejection fraction (LVEF), according to This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Laboratory measurements
Fasting blood samples of the survivors were collected concomitantly with the cardiac assessments. The following biomarkers were selected: NT-proBNP, a sensitive marker to 
Results
Characteristics of survivors and controls
As shown in the study flowchart ( Figure 1 Table 2 , the majority of survivors (86.4%) were female. Median age at cardiac evaluation of the survivors was 33 years (range 19 to 60 years), whereas the controls were aged 28 years (range 19 to 51 years) at evaluation (P = 0.027). Heart rate was significantly lower in survivors as compared to controls (P = 0.003). Survivors had a significantly higher fasting glucose (mean 5.0 vs. 4.5 mmol/L, P <0.001). However, none of the survivors or controls had diabetes mellitus. Two (3.0%) survivors vs. no controls had hypercholesterolemia. Hypertension was present in 9 (13.9%) survivors and 4 (6.1%) controls (P = 0.144). Finally, survivors were more often non-smokers as compared to controls (P = 0.017).
Echocardiography
Echocardiographic results are presented in Table 3 . LV mass index and left atrial volume index (LAVI) were comparable in survivors and controls. Regarding LV systolic function, median LVEF of survivors and controls was 58.8% (range 48.0 to 73.0%) and 60.0% (range 44.0 to 65.0%), respectively. In 11 survivors (16.7%) an eyeballing (estimated) LVEF was determined. One survivor had a LVEF <50%, while 5 controls had a LVEF <50% (P = 0.109).
Using sex-specific reference values from the American Society of Echocardiography, one (11.1%) male survivor and one male control had a LVEF <52% (P = 1.000), and 6 (10.5%) female survivors and 13 (23.6%, 2 missing) female controls had a LVEF <54% (P = 0.065) (14) . GLSS was available for 19 survivors. Median GLSS was -19.6% (range -24.2 to -17.6%).
A GLSS of -18% is considered the lower limit of the normal range for the equipment and This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
software used in this study. Two survivors (10.5%) had a GLSS >-18%, namely a GLSS of -17.6% and -17.7%, respectively, suggesting (near) normal systolic function in the survivors (14) . Median TAPSE, which represents a measure of RV systolic function, was 25.0 mm (range 17.0 to 33.7 mm) (14) . TAPSE values suggestive of RV dysfunction (i.e. <17.0 mm)
were not observed.
Diastolic dysfunction (using a strict definition) was present in 14 survivors (21.2%; median follow-up 21.4 years (range 6.8-to 42.9 years)), when compared with reference values from the literature (13) . To verify this finding in the Dutch situation, we compared the diastolic function of the survivors with that of the controls (Table 3 ). In the control group (n = 66), we found diastolic dysfunction in 10.6% of the participants (versus 21.2% of the survivors, P = 0.096). Echocardiographic measurements are depicted in Table 3 . Both septal and lateral e' were decreased compared to controls (P = 0.005 and P = 0.011, respectively), which confirms decreased diastolic function compared to controls. Early and late mitral valve inflow velocities were also lower in survivors compared to controls (both P <0.001). Seven survivors and one control had a LAVI >34 ml/m 2 , however, especially in many controls LAVI was lacking ( Table 3 ).
As shown in Table 4 and Supplemental Table 1 , the following variables were associated with diastolic function (e'mean) among the survivors of pediatric DTC in univariate analysis, and were eligible for multivariate analysis: attained age at evaluation, fasting glucose, cholesterol, diastolic blood pressure and waist circumference. TSH and cumulative radioiodine activity were not associated with diastolic function. Sex was added to the adjusted model. In the final adjusted model increasing attained age and waist circumference were associated with decreased diastolic function (β coefficient -0.134, 95%
CI -0.198 to -0.071, P <0.001 and β coefficient -0.091, 95% CI -0.136 to -0.046, P <0.001, respectively). A subanalysis showed no difference in the prevalence of diastolic This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Plasma biomarkers
Plasma levels of NT-proBNP, hs-Troponin-T and galectin-3 did not differ between survivors with and without diastolic dysfunction ( Table 5 ). The number of survivors with a NT-proBNP >125 ng/L or Galectin-3 >17.8 ng/mL also did not differ between survivors with and without diastolic dysfunction.
24-hour Holter electrocardiography
24-hour Holter ECGs of 65 (98.5%) survivors were available for analysis. All survivors showed sinus rhythm; AF was not observed.
Discussion
This is the first nationwide study on late cardiac effects in survivors of pediatric DTC,
showing frequent diastolic dysfunction in 21.2% of asymptomatic survivors after a median follow-up of 17 years, when compared to reference values from the literature and to a matched Dutch control group (13, 16) . As diastolic function declines with age, our findings may suggest early cardiac aging in survivors of pediatric DTC (15) . This is important, as diastolic dysfunction may be the first manifestation of more overt heart failure (17). We do believe that the fact that we did not find a statistically significant difference between survivors and controls with respect to prevalence of diastolic dysfunction (P = 0.096) might be due to the small numbers of studied subjects using a strict definition of diastolic dysfunction. Since we found significant differences when comparing the mitral valve inflow and diastolic tissue velocities, we conclude that the high percentage of diastolic dysfunction in survivors and the significant differences in echocardiographic measurements between survivors and controls might be clinically relevant.
In our cohort, increasing attained age and waist circumference were associated with decreased diastolic function, which are established risk factors for diastolic dysfunction (17). We hypothesized that TSH would also be associated with diastolic This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. significantly lower LVEF compared to controls, although LVEF remained within the reference range (9). The explanation for the different results may be, again, that survivors in our cohort were younger than those in the other studies.
Our finding of frequent diastolic dysfunction is in line with findings in other cohorts of long-term childhood cancer survivors (16, (25) (26) (27) (28) (29) . In those cohorts, systolic dysfunction has also been described (16, (25) (26) (27) (28) (29) . However, as survivors in those cohorts were treated with anthracyclines and/or mediastinal radiotherapy, the mechanisms that trigger cardiac dysfunction may differ.
The question remains which factors explain the diastolic dysfunction found in our cohort. The development of diastolic dysfunction is a multifactorial process (17). Patients have their individual cardiovascular risk factors, which make them more or less inclined to develop diastolic dysfunction. We hypothesize that thyroid cancer treatment causes more This study did not find an association between plasma levels of NT-proBNP, hs-Troponin-T and galectin-3 and diastolic dysfunction. An explanation for this may be that the diastolic dysfunction in our cohort was subclinical and therefore too mild to induce changes in plasma biomarkers. This implies that by measuring cardiac biomarkers alone, survivors with asymptomatic diastolic dysfunction could not be identified in our cohort.
AF was not observed using 24-hour ECG monitoring. In a cohort of adult survivors of DTC, an increased AF risk was described, independent of AF risk factors (11). However, in our study, survivors are significantly younger, and therefore had fewer risk factors for AF.
The strength of this study is that it is the first study of cardiac function in long-term survivors of pediatric DTC, and includes data on cardiovascular risk factors available for all subjects. Furthermore, detailed data on tumor and treatment characteristics (including both historical and current TSH values) and outcome were available for all survivors. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Assessment of GLSS was included in cardiac evaluation. Moreover, cardiac measurements were performed centrally, and interobserver variation was minimized, as the operator who performed all echocardiographic measurements in the survivors also performed these measurements in the control group (16) .
Some limitations require comment. First, due to small patient numbers this study may suffer from a lack of power and therefore mild cardiac effects may be missed. Second, due to a different age distribution in both cohorts, the controls were slightly younger than the survivors despite matching and therefore the diastolic dysfunction cannot exactly be dissociated from the effects of ageing per se. However, as reference data of the American Society of Echocardiography are adjusted per 20 years, in our opinion, a less than 5 years age difference is acceptable (13) . Third, control data were collected between 2004 and 2007, whereas the data of the survivors were collected between 2012 and 2014 using different echo techniques, which may introduce bias. However, both methods are strongly correlated and therefore important differences in diastolic function due to the different echo techniques are not expected (18). Fourth, biomarkers were available only for the survivors. Finally, various TSH assays were used. However, we expect that the assay differences had limited influence on the results because the lower limits of the reference ranges remained more or less stable. As discussed earlier, free T3 and T4 levels during follow-up were not available for our study.
In conclusion, diastolic dysfunction was observed in 21. Finally, it should be emphasized that cardiology follow-up together with regular communication between endocrinologists and cardiologists is required and that staging is mandatory before long-term, sometimes life-long, suppression treatment is implemented.
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